7521 - 7530 of 8654 Results
Title
Year
- Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson Disease2023OPENTitle: Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000207408Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10382272Citation Count: 10
- High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and Progression2023RESTRICTEDTitle: High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and ProgressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000207725Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10573147Citation Count: 16
-
OPENTitle: Screening for impulse control symptoms in patients with de novo Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 2Start Page: 176End Page: 180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31827b915cBest OA location URL: https://n.neurology.org/content/neurology/80/2/176.full.pdfCitation Count: 184
- α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity2009OPENTitle: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 41Issue #: 3Start Page: 308End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.300Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2683786Citation Count: 527
-
OPENTitle: Patterns of Motor and Non-Motor Features in Medication-Naïve ParkinsonismJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol: 45Issue #: 1Start Page: 59End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000437228Best OA location URL: https://www.karger.com/Article/Pdf/437228Citation Count: 10
-
OPENTitle: Estimating the Evolution of Disease in the Parkinson’s Progression Markers InitiativeJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 18Issue #: 4Start Page: 173End Page: 190Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000488780Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6314496Citation Count: 26
- Associations between Sleep Disorders and Impulsive-Compulsive Behaviors in Parkinson’s Disease: A Prospective Cohort Study2024OPENTitle: Associations between Sleep Disorders and Impulsive-Compulsive Behaviors in Parkinson’s Disease: A Prospective Cohort StudyJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol: 58Issue #: 4Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1159/000536555Best OA location URL: https://doi.org/10.1159/000536555Citation Count: 2
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease2015OPENTitle: Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 8Start Page: 864End Page: 870Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-311827Best OA location URL: http://doi.org/10.1136/jnnp-2015-311827Citation Count: 121
- Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease2016OPENTitle: Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 10Start Page: 1112End Page: 1122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-312690Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5154297Citation Count: 36
- Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort2017OPENTitle: Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohortJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2017-316213Best OA location URL: https://escholarship.org/uc/item/3jc4p43xCitation Count: 107